Venn sells Innovenn for €5.4m all-share deal
Clinical trials group selling technology development subsidiary to UK firm Integumen
Dublin-based Venn Life Sciences wins dual-listing approval
Venn approved to trade shares on Irish Stock Exchange’s ESM as well as on AIM
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices